Why is IMTX down?
Down 34% in 3 months while the S&P 500 fell 10%.
- It filed a prospectus for an offering of shares of $112.5M on Aug 25, 2026, its newest of 2 offering filings.
−3Long-term trend
Down 34% in 3 months while the S&P 500 fell 10%.
−3Long-term trend
IMTX's Quality Score rose 1 point on Fri, Nov 20, to -6. Trading was quieter than usual (2 chart checks started).
Follow IMTX's trial news. Pro members can get an alert when Immatics files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Holding it back | 25.3% more shares than a year ago |
| Latest filing | 6-K, Nov 10 |
Mon Jan 11: JP Morgan 45th Annual Healthcare…Investor conference · date confirmed.
After its last 4 reports it closed -0.9% on average, higher 0 of 4 times.
EUR 346M in cash
Chief Business Officer Rainer Kramer sold 22,868 shares on Nov 19. 1 more insider trade this year.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
IMTX is #207 of 273 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 207 |
Expected to report Thu Mar 4, before the open (in 103 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
A loss of €0.50 a share.
“The increase is mainly due to a higher milestone as well as higher level of activity and proportion of costs incurred relative to the overall plan in our collaboration programs within the quarter.”
IMTX's results filing gives no sales by line in a table we read. Its annual report gives the year's, in About.
No outlook figures read from this release.
“The increase is mainly driven by higher costs associated with the SUPRAME trial in the three months ended September 30, 2026.”
From its results filing (SEC filing · Nov 10)
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 10, 2026 | -1.7% | -0.2% | -4.0% |
| Aug 18, 2026 | -2.0% | -1.7% | -6.0% |
| May 12, 2026 | -0.5% | -1.3% | -8.0% |
RSI 29.3, MACD below signal, below both averages. Not scored.
One insider sold $139K across 1 filing in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
IMTX scores -6 today, which Breakaway calls Poor. It is #207 of 273 in Biotech by Quality Score, with 3 of 14 chart checks firing. Down 34% in 3 months while the S&P 500 fell 10%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
IMTX scores -6 today, which Breakaway calls Poor (below zero). That is #207 of 273 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind IMTX's -6.
One insider sold $139K across 1 filing in the last 6 months. No open-market buys on record. The newest is Rainer Kramer, Chief Business Officer, who sold $139K on Nov 19.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.